Your browser doesn't support javascript.
loading
Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma.
Rhee, Jiyoung; Jo, Jaemin; Han, Sang-Hoon; Kwon, Jung-Mi.
Afiliación
  • Rhee J; Division of Hematology-Oncology, Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea.
  • Jo J; Division of Hematology-Oncology, Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea.
  • Han SH; Division of Hematology-Oncology, Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea.
  • Kwon JM; Division of Hematology-Oncology, Department of Internal Medicine, Jeju National University Hospital, Jeju, Korea.
Ann Dermatol ; 31(2): 201-203, 2019 Apr.
Article en En | MEDLINE | ID: mdl-33911569
ABSTRACT
No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was treated with capecitabine and oxaliplatin after surgery for colon cancer. Surprisingly, he achieved a complete response for basal cell carcinoma. This is the first report of this chemotherapy regimen in basal cell carcinoma. This finding suggests that combination capecitabine and oxaliplatin can be a treatment option for patients unable to receive local therapy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Ann Dermatol Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Ann Dermatol Año: 2019 Tipo del documento: Article